Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc. - Current Ratioverified

INO

Price:

$1.115

Market Cap:

$59.75M

Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticulously engineered SynCon sequences to precisely identify and optimize the genetic blueprint of a target antigen. This innovative approach is supported by its CELLECTRA smart device technology, which efficiently delivers the DNA plasmids. Inovio is actively engaged in and planning clinical trials for its DNA medicines across a wide array of conditions. ...[Read more]

Industry

Biotechnology

IPO Date

1998-12-08

Stock Exchange

NASDAQ

Ticker

INO

The Current Ratio as of June 2026 (TTM) for Inovio Pharmaceuticals, Inc. (INO) is 1.04

According to Inovio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.04. This represents a change of -14.96% compared to the average of 1.22 of the last 4 quarters.

Inovio Pharmaceuticals, Inc. (INO) Historical Current Ratio (quarterly & annually)

How has INO Current Ratio performed in the past?

The mean historical Current Ratio of Inovio Pharmaceuticals, Inc. over the last ten years is 4.13. The current 1.04 Current Ratio has changed 2.42% with respect to the historical average. Over the past ten years (40 quarters), INO's Current Ratio was at its highest in in the March 2021 quarter at 14.17. The Current Ratio was at its lowest in in the September 2025 quarter at 0.79.

Quarterly (TTM)
Annual

Average

4.13

Median

3.10

Minimum

1.40

Maximum

11.30

Inovio Pharmaceuticals, Inc. (INO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Inovio Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 283.65%

Maximum Annual Current Ratio = 11.30

Minimum Annual Increase = -52.29%

Minimum Annual Current Ratio = 1.40

Quarterly (TTM)
Annual
YearCurrent RatioChange
20251.40-49.46%
20242.77-23.00%
20233.6010.52%
20223.25-52.29%
20216.82-39.62%
202011.30283.65%
20192.9418.37%
20182.49-36.34%
20173.9137.45%
20162.84-47.94%

Inovio Pharmaceuticals, Inc. (INO) Average Current Ratio

How has INO Current Ratio performed in the past?

The current Current Ratio of Inovio Pharmaceuticals, Inc. (INO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.59

5-year avg

3.57

10-year avg

4.13

Inovio Pharmaceuticals, Inc. (INO) Current Ratio vs. Peers

How is INO’s Current Ratio compared to its peers?

Inovio Pharmaceuticals, Inc.’s Current Ratio is less than Acumen Pharmaceuticals, Inc. (4.55), less than Opus Genetics, Inc. (7.13), greater than Agenus Inc. (0.38), less than Seer, Inc. (17.73), less than Spero Therapeutics, Inc. (10.50), less than Fate Therapeutics, Inc. (5.85), less than Seres Therapeutics, Inc. (1.65), less than VistaGen Therapeutics, Inc. (3.67), less than Alector, Inc. (5.25), less than Actuate Therapeutics Inc (1.80),

Build a custom stock screener for Inovio Pharmaceuticals, Inc. (INO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Inovio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Inovio Pharmaceuticals, Inc. (INO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Inovio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Inovio Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Inovio Pharmaceuticals, Inc. (INO)?

What is the highest Current Ratio for Inovio Pharmaceuticals, Inc. (INO)?

What is the 3-year average Current Ratio for Inovio Pharmaceuticals, Inc. (INO)?

What is the 5-year average Current Ratio for Inovio Pharmaceuticals, Inc. (INO)?

How does the current Current Ratio for Inovio Pharmaceuticals, Inc. (INO) compare to its historical average?